CATRENE Programme to Succeed MEDEA+ as European Nanoelectronics R&D Champion

MEDEA+, the EUREKA pan-European Programme for advanced co-operative Research and Development in Microelectronics, today announced details of the new EUREKA programme called CATRENE (Cluster for Application and Technology Research in Europe on NanoElectronics) that will take up the challenge of increasing Europe's strength in micro- and nanoelectronics after the highly successful MEDEA+ programme reaches its conclusion in 2008. A public/private partnership aimed at ensuring the continued development of European expertise in semiconductor technology and applications, CATRENE will build on the success of MEDEA+ and the previous EUREKA programmes JESSI and MEDEA in fostering the continued development of a dynamic European ecosystem with the critical mass necessary to compete at a global level in high technology industries as these move into the era of nanoelectronics.

Since its inception in 2001, MEDEA+ has made significant contributions to establishing and maintaining European leadership in fields ranging from smart card and image sensing technologies to automotive electronics. European IC companies have successfully developed three basic CMOS process generations in a time schedule in line with or even ahead of the global ITRS roadmap. Three European semiconductor companies are ranked amongst the world wide top ten and Europe's semiconductor industry has 10% of the world wide market. European champions with a strong global market position as wafer processing equipment suppliers, lithography tool and infrastructure suppliers as well as substrate and material suppliers have been added to the industrial landscape.

Like MEDEA+, CATRENE embraces all key actors in the value chain - including applications, technology, materials and equipment suppliers - as well as involving industrial companies of all sizes, universities and other research institutions, supported by Public Authorities. In this way CATRENE will benefit from the strong infrastructure for cross-border cooperation that has been developed by MEDEA+ and its predecessors.

An important feature of CATRENE is the concept of Lighthouse Projects, which address major socioeconomic needs such as transportation, healthcare, security, energy and entertainment through focussed R&D programmes. In the foreseeable future, the role of electronics and information systems will further increase as European society is faced with structural problems such as ageing of the population, exploding healthcare cost, transportation bottlenecks, rising energy costs and the need to increase productivity to be competitive on a worldwide basis. These societal challenges are also major opportunities for European industry and are designed to help European companies to address these new lead markets and to become worldwide market leaders. The "umbrella" lighthouse projects will serve as a focus for specific technology and applications development projects that address these challenges.

"For more than a decade, the EUREKA JESSI, MEDEA and MEDEA+ programmes have made it possi-ble for Europe's industry to reinforce its position in semiconductor process technology, manufac-turing and applications, and to become a key supplier to markets such as telecommunications, consumer electronics and automotive electronics", said Jozef Cornu, Chairman of MEDEA+ and designated Chairman of CATRENE. "Nanoelectronics will offer enormous opportunities to those who are the first to master and bring to market new technologies and applications and we believe that CATRENE will play a vital role in helping Europe's microelectronics industry to go from strength to strength."

While the JESSI, MEDEA and MEDEA+ programmes were divided into technology and applications sub-programmes, CATRENE recognises the increasing convergence of technology and applications. It will therefore focus on large identified application markets, deriving from these the roadmap of required technologies. Key technology goals include maintaining and increasing Europe's strength in IP (Intellectual Property) across the entire electronics supply chain and its leadership in lithography and Silicon-on-Insulator materials; ensuring that European companies are among the world leaders in the advanced semiconductor technologies that allow entire systems to be integrated in a single package; and strengthening European expertise in applying a deep knowledge of semiconductor process technology to efficient design for new electronics applications.

For more information on MEDEA+ and CATRENE visit http://www.medeaplus.org.

About MEDEA+
The MEDEA+ programme (2001-2008) comprised 77 projects involving 20,000 person-years and around 450 partner organisations from large companies (38 %), SMEs (37%), institutes and academia (25%). It delivered important innovations in key application areas such as automotive and traffic control, broadband communications, secure society, energy saving and healthcare.

About CATRENE
CATRENE is a four-year programme, starting 1 January 2008 and extendable by another four years. This is in line with the changing landscape of the semiconductor industry as well as the present view on technology evolution and the time span over which most of the major applications will develop. Resources required will be annually around 4,000 person-years, equalling about € 6 billion for the extended programme.

Most Popular Now

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...

AI can Strengthen Pandemic Preparedness

How to identify the next dangerous virus before it spreads among people is the central question in a new Comment in The Lancet Infectious Diseases. In it, researchers discuss how...

'Future-Guided' AI Improves Se…

In the world around us, many things exist in the context of time: a bird’s path through the sky is understood as different positions over a period of time, and...

New AI Tool Scans Social Media for Hidde…

A new artificial intelligence tool can scan social media data to discover adverse events associated with consumer health products, according to a study published September 30th in the open-access journal...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...